Obesity Drugs Linked to Lower Cancer Risk

Published on May 19, 2025

Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study says. First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of…

Read Full Article (External Site)